Search Results - "Schober, O"

Refine Results
  1. 1

    Imaging of Irreversible Loss of Brain Function by Lanfermann, H, Schober, O

    “…The updated guidelines for the determination of irreversible loss of brain function include a substantial innovation, i. e., the use of CT angiography as a…”
    Get more information
    Journal Article
  2. 2

    Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET by Wagner, S, Breyholz, H-J, Faust, A, Höltke, C, Levkau, B, Schober, O, Schäfers, M, Kopka, K

    Published in Current medicinal chemistry (01-10-2006)
    “…Matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent secreted or membrane anchored endopeptidases. MMPs are involved in many…”
    Get more information
    Journal Article
  3. 3

    O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours by Weckesser, M, Langen, K J, Rickert, C H, Kloska, S, Straeter, R, Hamacher, K, Kurlemann, G, Wassmann, H, Coenen, H H, Schober, O

    “…The aim of this study was to evaluate the differential uptake of O-(2-[18F]fluorethyl)-L-tyrosine (FET) in suspected primary brain tumours. Positron emission…”
    Get full text
    Journal Article
  4. 4

    Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults: Comparison with Skeletal Scintigraphy and FDG PET by Daldrup-Link, Heike E, Franzius, Christiane, Link, Thomas M, Laukamp, Daniela, Sciuk, Joachim, Jurgens, Heribert, Schober, Otmar, Rummeny, Ernst J

    Published in American journal of roentgenology (1976) (01-07-2001)
    “…The purpose of this study was to compare the diagnostic accuracy of whole-body MR imaging, skeletal scintigraphy, and 18F-fluorodeoxyglucose (FDG) positron…”
    Get full text
    Journal Article
  5. 5

    Small animal PET in preclinical studies: opportunities and challenges by Riemann, B, Schäfers, K P, Schober, O, Schäfers, M

    “…The process of drug and molecular imaging development is strongly influenced by the revolution of non-invasive imaging techniques. Small animal positron…”
    Get full text
    Journal Article
  6. 6

    Peace of mind for patients with differentiated thyroid cancer? by Vrachimis, A, Riemann, B, Gerss, J, Maier, T, Schober, O

    Published in Nuclear medicine (2013)
    “…Differentiated thyroid carcinomas (DTC) have an excellent prognosis, with 10-year overall survival rates over 90%. In addition, DTC patients benefit from their…”
    Get more information
    Journal Article
  7. 7

    Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation by Vrachimis, A, Schober, O, Riemann, B

    Published in Nuclear medicine (2012)
    “…Radioiodine remnant ablation (RRA) after (near-)total thyroidectomy (TE) is a key element in patients with differentiated thyroid cancer (DTC). The use of…”
    Get more information
    Journal Article
  8. 8

    Multimodality molecular imaging — from target description to clinical studies by Schober, O., Rahbar, K., Riemann, B.

    “…This highlight lecture was presented at the closing session of the Annual Congress of the European Association of Nuclear Medicine (EANM) in Munich on 15…”
    Get full text
    Journal Article
  9. 9

    FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT by Franzius, C., Daldrup-Link, H. E., Sciuk, J., Rummeny, E. J., Bielack, S., Jürgens, H., Schober, O.

    Published in Annals of oncology (01-04-2001)
    “…Background The purpose was the comparison of positron emission tomography using F-18-fluorodeoxy-glucose (FDG-PET) and spiral thoracic CT to detect pulmonary…”
    Get full text
    Journal Article
  10. 10

    FDG–PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging by Franzius, C., Daldrup-Link, H. E., Wagner-Bohn, A., Sciuk, J., Heindel, W. L., Jürgens, H., Schober, O.

    Published in Annals of oncology (01-01-2002)
    “…Background The aim of this study was to assess the diagnostic ability of positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG–PET)…”
    Get full text
    Journal Article
  11. 11

    Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3) by Dietlein, M, Dressler, J, Eschner, W, Grünwald, F, Lassmann, M, Leisner, B, Luster, M, Moser, E, Reiners, Chr, Schicha, H, Schober, O

    Published in Nuclear medicine (2007)
    “…The procedure guideline for radioiodine therapy (RIT) of differentiated thyroid cancer (version 3) is the counterpart to the procedure guideline for (131)I…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications by Waerzeggers, Y, Ullrich, R T, Monfared, P, Viel, T, Weckesser, M, Stummer, W, Schober, O, Winkeler, A, Jacobs, A H

    Published in British journal of radiology (01-12-2011)
    “…A deeper understanding of the role of specific genes, proteins, pathways and networks in health and disease, coupled with the development of technologies to…”
    Get full text
    Journal Article
  15. 15

    Survival of differentiated thyroid carcinoma studied in 500 patients by Lerch, H, Schober, O, Kuwert, T, Saur, H B

    Published in Journal of clinical oncology (01-05-1997)
    “…To analyze the factors that influence survival of patients with differentiated thyroid carcinoma treated by surgical thyroidectomy, radioactive iodine, and…”
    Get more information
    Journal Article
  16. 16

    Myocardial perfusion scintigraphy - short form of the German guideline by Lindner, O, Burchert, W, Hacker, M, Schaefer, W, Schmidt, M, Schober, O, Schwaiger, M, vom Dahl, J, Zimmermann, R, Schäfers, M

    Published in Nuclear medicine (2013)
    “…This guideline is a short summary of the guideline for myocardial perfusion scintigraphy published by the Association of the Scientific Medical Societies in…”
    Get more information
    Journal Article
  17. 17

    Guideline for radioiodine therapy for benign thyroid diseases (version 4) by Dietlein, M, Dressler, J, Grünwald, F, Leisner, B, Moser, E, Reiners, Chr, Schicha, H, Schneider, P, Schober, O

    Published in Nuclear medicine (2007)
    “…Version 4 of the guideline for radioiodine therapy for benign thyroid diseases includes an interdisciplinary consensus on decision making for antithyroid…”
    Get more information
    Journal Article
  18. 18

    Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? by Juergens, K U, Weckesser, M, Stegger, L, Franzius, C, Beetz, M, Schober, O, Heindel, W, Wormanns, D

    Published in European radiology (01-05-2006)
    “…For optimal image fusion between CT and F-18-FDG-PET, the acquisition of CT images is performed in mild expiratory suspension, which might compromise the…”
    Get full text
    Journal Article
  19. 19

    Procedure guideline for sentinel lymph node diagnosis by Vogt, H, Schmidt, M, Bares, R, Brenner, W, Grünwald, F, Kopp, J, Reiners, C, Schober, O, Schümichen, C, Schicha, H, Sciuk, J, Sudbrock, F, Wengenmair, H

    Published in Nuclear medicine (2010)
    “…The authors present a procedure guideline for scintigraphic detection of sentinel lymph nodes in malignant melanoma and other skin tumours, in breast cancer,…”
    Get more information
    Journal Article
  20. 20